Clinical Trial Update: Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

View source ↗

Summary

A Columbia University–sponsored clinical trial evaluating cardiovascular risk markers in growth hormone-deficient patients with nonsecreting pituitary adenomas;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Pituitary Tumor

Snippet

Sponsor: Columbia University | Conditions: Growth Hormone Deficiency, Pituitary Tumor | Status: TERMINATED